Second CanSERV Open Call to support cancer research


Published: 2024-04-10

Euro-BioImaging is pleased to announce that the second Open Call from the Horizon Europe-funded canSERV project is here! Cancer Researchers are invited to apply for FREE state-of-the-art services and training at several European Research Infrastructures, including Euro-BioImaging ERIC. Within this project, 28 Euro-Bioimaging Nodes offer access to their expertise. It’s an amazing opportunity for the cancer research community to access a wide-ranging portfolio of services.

canSERV invites applications covering the entire range of the oncology developmental pipeline, from supporting discoveries in fundamental research to translational science and personalised oncology, addressing at least one of the four strategic goals of the Cancer Mission:

Researchers from academia, industry and SMEs may apply for several service categories including:

Submission deadline is May 21, 2024.

For more information and call text please visit the CanSERV project website www.canSERV.eu/Calls or contact us at canservprojects@eurobioimaging.eu.

About canSERV

As part of a concerted strategy to tackle the challenges of cancer, the EU-funded project canSERV offers more than 400 innovative cancer research technologies to European and non-European cancer researchers at all levels. The service, or a combination of services and training, can be requested to accelerate ground-breaking discoveries and their translation into clinical applications.

In line with Europe’s Cancer Mission and Beating Cancer Plan, canSERV promotes the development of concrete solutions for cancer by providing a comprehensive set of world-class oncology technologies and state of the art training to cancer scientists.

canSERV Enables Researchers to Cover the Entire Range of the Oncology Developmental Pipeline. 



We use cookies to manage and improve the services of the Euro-BioImaging Web Portal. To find out more, read our Privacy policy.
Please note: For best experience we do not recommend using Internet Explorer.